<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>the akampioneer &#187; Company News</title>
	<atom:link href="http://akampioneer.com/category/company-news/feed" rel="self" type="application/rss+xml" />
	<link>http://akampioneer.com</link>
	<description></description>
	<lastBuildDate>Thu, 02 Feb 2012 19:00:15 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.1</generator>
		<item>
		<title>Company News: Anergis Appoints Jacques-François Martin as Chairman of the Board of Directors</title>
		<link>http://akampioneer.com/company-news/company-news-anergis-appoints-jacques-francois-martin-as-chairman-of-the-board-of-directors.html</link>
		<comments>http://akampioneer.com/company-news/company-news-anergis-appoints-jacques-francois-martin-as-chairman-of-the-board-of-directors.html#comments</comments>
		<pubDate>Wed, 01 Feb 2012 09:02:20 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Company News]]></category>
		<category><![CDATA[allergies]]></category>
		<category><![CDATA[allergy vaccines]]></category>
		<category><![CDATA[AllerT]]></category>
		<category><![CDATA[Anergis]]></category>
		<category><![CDATA[Chairman of the Board of Directors]]></category>
		<category><![CDATA[Chiron Vaccines]]></category>
		<category><![CDATA[Contiguous Overlapping Peptides (“COPs”)]]></category>
		<category><![CDATA[desensibilization]]></category>
		<category><![CDATA[Jacques-François Martin]]></category>
		<category><![CDATA[Markus Hosang]]></category>
		<category><![CDATA[Mymetics Corporation]]></category>
		<category><![CDATA[Pasteur-Mérieux]]></category>
		<category><![CDATA[The Vaccine Fund]]></category>
		<category><![CDATA[Vincent Charlon]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=2025</guid>
		<description><![CDATA[Anergis, a clinical-stage biopharmaceutical company developing novel allergy vaccines, today announced the appointment of Jacques-François Martin, Chairman and CEO of vaccine company Mymetics, as Chairman of the Board of Directors. Anergis develops allergy vaccines based on its proprietary technology of “Contiguous Overlapping Peptides” (“COPs”). Anergis’ lead allergy vaccine, called “AllerT”, is in clinical Phase IIb [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/company-news/company-news-anergis-appoints-jacques-francois-martin-as-chairman-of-the-board-of-directors.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company News: bubbles &amp; beyond presents product update and outlook at nanotech 2012</title>
		<link>http://akampioneer.com/company-news/company-news-bubbles-beyond-presents-product-update-and-outlook-at-nanotech-2012.html</link>
		<comments>http://akampioneer.com/company-news/company-news-bubbles-beyond-presents-product-update-and-outlook-at-nanotech-2012.html#comments</comments>
		<pubDate>Mon, 30 Jan 2012 10:20:46 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Company News]]></category>
		<category><![CDATA[bubbles & beyond]]></category>
		<category><![CDATA[cleaning]]></category>
		<category><![CDATA[cosmetics]]></category>
		<category><![CDATA[enpurex(R)]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[industrial applications]]></category>
		<category><![CDATA[intelligent fluids(R)]]></category>
		<category><![CDATA[JNC-CHISSO]]></category>
		<category><![CDATA[microelectronics]]></category>
		<category><![CDATA[milestones]]></category>
		<category><![CDATA[nanotech 2012]]></category>
		<category><![CDATA[outlook]]></category>
		<category><![CDATA[phase fluids]]></category>
		<category><![CDATA[printing industry]]></category>
		<category><![CDATA[product update]]></category>
		<category><![CDATA[protecting]]></category>
		<category><![CDATA[Rolf Meyer GmbH]]></category>
		<category><![CDATA[surface modification]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=2014</guid>
		<description><![CDATA[bubbles &#38; beyond, a technology company focusing on customized intelligent fluids®, today announced that the company will present its current product portfolio and business strategy for 2012 at the upcoming nanotech 2012 conference in Tokyo, Japan (Feb. 15-17). Intelligent fluids® are customized phase fluids, which are primarily designed for cleaning, separating and protecting surfaces. They [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/company-news/company-news-bubbles-beyond-presents-product-update-and-outlook-at-nanotech-2012.html/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Company News: Amgen to Acquire Micromet</title>
		<link>http://akampioneer.com/company-news/company-news-amgen-to-acquire-micromet.html</link>
		<comments>http://akampioneer.com/company-news/company-news-amgen-to-acquire-micromet.html#comments</comments>
		<pubDate>Thu, 26 Jan 2012 13:12:08 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Company News]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=2006</guid>
		<description><![CDATA[Amgen (NASDAQ: AMGN) and Micromet, Inc. (NASDAQ: MITI) today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded inGermany with its research and development (R&#38;D) center in Munich and headquarters in Rockville, Md., for $11 per share in cash. The transaction, which values Micromet at approximately $1.16 billion, was unanimously approved by [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/company-news/company-news-amgen-to-acquire-micromet.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company News: Nanohale AG acquires R&amp;D and service units of Scil Technology GmbH</title>
		<link>http://akampioneer.com/company-news/company-news-nanohale-ag-acquires-rd-and-service-units-of-scil-technology-gmbh.html</link>
		<comments>http://akampioneer.com/company-news/company-news-nanohale-ag-acquires-rd-and-service-units-of-scil-technology-gmbh.html#comments</comments>
		<pubDate>Mon, 09 Jan 2012 09:05:04 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Company News]]></category>
		<category><![CDATA[analytics]]></category>
		<category><![CDATA[asset deal]]></category>
		<category><![CDATA[BioNet Holding]]></category>
		<category><![CDATA[Christian Nafe]]></category>
		<category><![CDATA[exit]]></category>
		<category><![CDATA[formulation]]></category>
		<category><![CDATA[formycon]]></category>
		<category><![CDATA[Medtronic Inc.]]></category>
		<category><![CDATA[Nanohale]]></category>
		<category><![CDATA[protein drug development]]></category>
		<category><![CDATA[R&D and service units]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[Scil Technology]]></category>
		<category><![CDATA[tissue regeneration projects]]></category>
		<category><![CDATA[transaction]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=1962</guid>
		<description><![CDATA[- Transaction creates new Nanohale subsidiary named Formycon GmbH - Scil Technology GmbH and Nanohale AG today announced that Nanohale has acquired the entire R&#38;D, contract development and manufacturing organization of Scil Technology GmbH in an asset deal, effective December 31, 2011. Employees and inventory of Scil Technology GmbH have become part of Formycon GmbH, [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/company-news/company-news-nanohale-ag-acquires-rd-and-service-units-of-scil-technology-gmbh.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company News: Rolf Meyer GmbH Exclusively Acquires Worldwide Distribution Rights for enpurex® Product Portfolio from bubbles &amp; beyond</title>
		<link>http://akampioneer.com/company-news/company-news-rolf-meyer-gmbh-exclusively-acquires-worldwide-distribution-rights-for-enpurex%c2%ae-product-portfolio-from-bubbles-beyond.html</link>
		<comments>http://akampioneer.com/company-news/company-news-rolf-meyer-gmbh-exclusively-acquires-worldwide-distribution-rights-for-enpurex%c2%ae-product-portfolio-from-bubbles-beyond.html#comments</comments>
		<pubDate>Tue, 20 Dec 2011 09:34:30 +0000</pubDate>
		<dc:creator>akampion</dc:creator>
				<category><![CDATA[Company News]]></category>
		<category><![CDATA[bubbles & beyond]]></category>
		<category><![CDATA[distribution rights]]></category>
		<category><![CDATA[enpurex cleansers]]></category>
		<category><![CDATA[enpurex(R)]]></category>
		<category><![CDATA[green printing]]></category>
		<category><![CDATA[intelligent fluids(R)]]></category>
		<category><![CDATA[optimum safety and efficacy]]></category>
		<category><![CDATA[print industry cleansing products]]></category>
		<category><![CDATA[Rolf Meyer GmbH]]></category>
		<category><![CDATA[worldwide sales]]></category>

		<guid isPermaLink="false">http://akampioneer.com/?p=1945</guid>
		<description><![CDATA[- Innovative cleaners for the printing industry now available worldwide - bubbles &#38; beyond, a technology company focusing on customized intelligent fluids®, today announced that Rolf Meyer GmbH has acquired the exclusive global sales and distribution rights for the enpurex® print industry cleansing products, effective January 1, 2012. At present, the enpurex® product portfolio comprises [...]]]></description>
		<wfw:commentRss>http://akampioneer.com/company-news/company-news-rolf-meyer-gmbh-exclusively-acquires-worldwide-distribution-rights-for-enpurex%c2%ae-product-portfolio-from-bubbles-beyond.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

